Skip to content

Effect of a plant extract containing dietary supplement on psychopathologic stress reactions among healthy participants

Effect of a plant extract containing dietary supplement on psychopathologic stress reactions among healthy participants - SB-SID 0213

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00006008
Enrollment
60
Registered
2014-04-09
Start date
2014-04-11
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

STRESS Healthy volunteers

Interventions

Group 1: Over a period of six weeks, study participants ingests twice daily one capsule. Main ingredients of this capsules are vitamines (B1, B6, B12, Folic acid) and a plantextract of Sideritis scard

Sponsors

Schaper & Brümmer GmbH & Co. KG
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 60 Years

Inclusion criteria

Inclusion criteria: • Age: 25-60 years • Men and Women • Non-smokers • written consent after information about study contents and study procedure • Ability and willingness of study participants to follow study leaders instructions

Exclusion criteria

Exclusion criteria: • severe chronic illness (manifest coronary heart disease, cancer, • insulin-dependent diabetes mellitus Typ I and II), severe kidney or liver diseases • Psychological diseases (ADHS, Depression, panic, anxiety) • food allergies, known endokrine and immunological diseases • chronic gastroinestinal diseases (especially small intestine e.g. duodenal ulcer, liver, pancreas) and state after gastrointestinal surgical procedure e.g. nontropical sprue, short bowel syndrome), stomach stapling operations, gastric band • oral mucositis, dental diseases, inflammation in the oral cavity • Hormonal disorders, for example, hyperthyroidism and Cushing's syndrome • heart surgery (Stent, Bypass, Heart pacemaker/ gastrointestinal surgery (not: elimination of appendix or gall bladder) • • immediate planned surgery • addiction to alcohol and/or drugs • Pregnancy, lactation • Smokers • Persons with body mass index > 30 • Persons who are not able or not allowed to give written consent • simultaneous participation at another clinical trial or participation within the last 30 days

Design outcomes

Primary

MeasureTime frame
Stress tolerance (six weeks after first examination (t6) in comparison to first examination (t0)), respectivly measured as changes of the cognitive performance and visual attentnion under stress, using the Trail Making Test (TMT), before and after an acute stress impulse.

Secondary

MeasureTime frame
• stress tolerance (six weeks after first examination (t6) in comparison to first examination (t0)), respectively measured by changes in the cognitive performance and visuell attention in the Colour Word Test (CWT) (Duration: 10 minutes) • subjective stress perception (six weeks after first examination (t6) in comparison to first examination (t0)) (according to the Perceived Stress Questionnaire) • acute subjective stress perception (six weeks after first examination (t6) in comparison to first examination (t0)) (according to General Stress Questionnaire) before and after an acute stress impulse.

Countries

Germany

Contacts

Public ContactIsabel Behrendt

Institut für Lebensmittelwissenschaft und Humanernährung

behrendt@nutrition.uni-hannover.de0511 762 3317

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026